Journal of Chemistry

Journal of Chemistry / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 1739879 | 7 pages | https://doi.org/10.1155/2016/1739879

A Simple and Convenient Method for Simultaneous Determination of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C

Academic Editor: Pranav S. Shrivastav
Received21 Mar 2016
Revised23 May 2016
Accepted19 Jul 2016
Published13 Oct 2016

Abstract

A simple, rapid, and specific HPLC method was established for simultaneous determination of five major lignans (Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C) in Schisandra chinensis. The five lignans can be separated completely on Kromasil C18 column (250 nm × 4.6 nm) and then detected at 254 nm using methanol (mobile phase A) and water (mobile phase B) with gradient elution as the mobile phase at 1.0 mL/min flow rate. The column temperature was 30°C. The method was validated in terms of linearity, precision, stability, repeatability, and recovery. Results showed that the method is accurate and reproducible.

1. Introduction

The dried ripe fruit of Schisandra chinensis (S. chinensis) has been used for many years in traditional Chinese medicine. Modern pharmacological studies show that S. chinensis has many biological activities, such as for liver protection [1], hypnogenesis, sedation [2], antioxidative stress [3], vasodilation, anti-inflammation [4], anticancer, immunity enhancement, and anticardiovascular disease [5]. In addition, this species is approved for common food and health food utilization because of its efficiency and safety. S. chinensis is one of the most widely used and studied herbs in Asia; this herb is added in common food, health food, and Chinese multiherb remedies in China. Therefore, establishing a simple and convenient method for quantitative analysis of the bioactive compounds of S. chinensis is rather important and necessary. The fruit of S. chinensis has been proven to contain a variety of pharmacologically active lignans, particularly those with a dibenzocyclooctadiene skeleton. Most of the pharmacological properties of S. chinensis have been attributed to these compounds. Among the bioactive compounds, Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C are the most effective.

Owing to the importance of lignans, some methods for lignan detection have been developed [6, 7]. Liu et al. established a method of detecting nine lignans in 48 min by HPLC-DAD-MS combined with Chemometrics [8]. Kim et al. established a method to detect three lignans by online TLC-DART-MS [9]. Zhang et al. developed a matrix solid-phase dispersion extraction combined with high-performance liquid chromatography for determination of five lignans from the Schisandra chinensis [10]. Given that most methods require expensive equipment such as mass spectrometry (MS), it only can be used by many researchers equipped with MS [1113].

Therefore, some simple method which does not need expensive equipment is needed for the researchers.

In the present study, Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were detected by a simple and easy method based on HPLC-DAD. The novel and simple method can be utilized in the study and research of the S. chinensis, especially for the undeveloped and developing areas. And because of the short detection time, it is also useful to the researchers who need to detect their contents often.

2. Experiment

2.1. Reagents

HPLC grade methanol was used in the experiments. Ultrapure water was obtained using the Milli-Q system (Millipore, Bedford, MA, USA) and used in the entire test. Standards for quantitative analysis were purchased from the National Institution for Food and Drug Control.

2.2. Instrumentation and Analytical Conditions

HPLC system 1200 series (Agilent Technologies, USA) equipped with Chemstation B.03.02 software (Agilent Technologies, USA), which were comprised of a quaternary solvent delivery pump, an online vacuum degasser, an autosampler, a thermostated compartment, and diode array detector (DAD), were used for chromatographic analysis. All separation processes were performed using a Kromasil C18 column (250 mm × 4.6 mm i.d. with 5.0 μm particle size).

Mobile phase A was methanol and phase B was water. The linear gradient condition (30% B for 0 min to 8 min; 30% to 20% B for 8 min to 12 min; 20% to 10% B for 12 min to 20 min; 10% B for 20 min to 30 min) was applied for the separation process. The five lignans can be separated completely by employing this process. The flow rate was 1.0 mL/min, and the column temperature was 30°C, which was maintained for the entire experiment. The eluate was monitored at 254 nm, and the injection volume was 20 μL. The peak identification was based on the retention time and DAD spectrum against the standard presented in the chromatogram.

2.3. Preparation of the Standard Solution

Quantification was based on the external standard method. The stock solutions of each analyte were prepared by dissolving these standards in methanol. The solutions were separately and accurately prepared as follows: Schizandrol A (0.0032 g), Schizandrol B (0.0042 g), Schisandrin A (0.0046 g), γ-Schisandrin (0.0032 g), and Schisandrin C (0.0040 g) were placed in centrifugal tubes, in which 2, 2, 2, 2, and 2.5 mL of methanol were then added, respectively. After 10 min ultrasonication, the final concentrations were 1600 μg/mL Schizandrol A, 2100 μg/mL Schizandrol B, 2300 μg/mL Schisandrin A, 1600 μg/mL γ-Schisandrin, and 1600 μg/mL Schisandrin C. All of the solutions were stored at −4°C.

The working standard solutions were prepared using the stock solutions. The appropriate stock solutions and methanol were mixed well. Finally, the working standard solutions (800, 262.5, 287.5, 200, and 200 μg/mL) of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were prepared. Subsequently, the mixed standard work solutions (1.25 μg/mL to 300 μg/mL) of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were prepared by using the working standard solutions. These preparations are presented in Table 1. All of the solutions were stored at −4°C.


Concentration 12345678

Schizandrol A (μg/mL)320.0240.0160.080.04020105.0
Schizandrol B (μg/mL)105.078.852.526.313.16.63.31.6
Schisandrin A (μg/mL)115.086.357.528.814.47.23.61.8
γ-Schisandrin (μg/mL)80.060.040.020.010.05.02.51.3
Schisandrin C (μg/mL)80.060.040.020.010.05.02.51.3

2.4. Sample Extraction Procedure

Dry (without mildew) S. chinensis were pulverized using medicinal herb grinders. The powdered sample was weighed accurately and soaked in 80% ethanol for 12 h (1 : 12 material-to-solvent ratio). The powdered sample was refluxed using 80% ethanol for 2 h; this process was repeated three times at 90°C. The extracts were combined before being filtered by the filter and then diluted with 80% ethanol until the final volume of 0.25 g herbs/mL was reached. The diluted solution was filtered through a syringe filter (0.45 μm) and then stored at −4°C before injection.

3. Results and Discussion

3.1. Wavelength Optimization

The five bioactive compounds were scanned between 190 and 400 nm using the UV detector. The maximum absorbance values of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were 217, 204, 207, 214, and 219 nm, respectively. Given the serious end absorption near 210 nm, the detection wavelength was set at 254 nm, in which all of the compounds have apparent absorption band. The results are shown in Figure 1.

3.2. Detector Optimization

The DAD detector can detect not only one or few but all wavelengths. Therefore, analyzing the characteristic absorption and retention time of the analyte was easier. A general analysis can be made using the characteristic absorption and retention time. In this way, the error rate is remarkably reduced and conveniently used in the assessment of each chromatographic peak of the corresponding materials.

3.3. Mobile Phase Optimization

Various organic solvents in different ratios resulted in different peak separations. The composition and ratios of the mobile phase were optimized using different organic solvents, which include methanol, acetonitrile, and water in different concentrations. In the present study, the mobile phase composition was selected as mobile phase for the simultaneous analysis because of better resolution and shorter analysis time than other phases. Typical HPLC-PDA chromatograms of the standard samples are presented in Figures 2 and 3.

3.4. Preparation of the Standard Curve

Under optimized chromatographic condition, the mixed working standards with different concentrations were injected (three replicates), and then the peak areas were recorded. Average values for the three repetitions were presented as the final results. The peak area and the corresponding concentration are presented in Table 1. The stand curve is established by linear regression analysis of the concentration and the peak area. The standard curve of each analyte was found to be linear (Table 2).


Regression equationLinear range (g/mL)

Schizandrol A5.000–320.000
Schizandrol B1.641–105.000
Schisandrin A1.800–115.000
γ-Schisandrin1.250–80.000
Schisandrin C1.250–80.000

3.5. Precision

Precision was measured by intra- and interday variabilities. The mixed working standard solutions of low, medium, and high concentrations were analyzed to calculate the relative standard deviation (RSD). The intraday precision was determined by five-time repeated analysis of same samples. Average values were used in RSD calculation. The RSDs of the low-concentration solutions were 0.47%, 0.77%, 1.72%, 1.62%, and 0.56% (). The RSDs of the medium-concentration solutions were 0.16%, 0.17%, 0.11%, 0.11%, and 0.10% (). Finally, the RSDs of the high-concentration solutions were 0.15%, 0.16%, 0.09%, 0.13%, and 0.13% (). The results are presented in Tables 35.


RSD (%)

Schizandrol A239.7240.4238238.3237.90.47
Schizandrol B5959.458.358.758.40.77
Schisandrin A88.687.684.786.186.41.72
γ-Schisandrin44.443.943.442.942.71.62
Schisandrin C44.644.544.244.544.90.56


RSD (%)

Schizandrol A3697.43704.63710.53705.83712.70.16
Schizandrol B911.5913.2914.9914915.40.17
Schisandrin A1270.11272.21273.31273.91272.50.11
γ-Schisandrin672.2672.6674673.5673.60.11
Schisandrin C693.1694.2694.2694.66950.10


RSD (%)

Schizandrol A14726.314727.914736.114760.914775.20.15
Schizandrol B3549.53546.83551.33557.23560.70.16
Schisandrin A4911.34913.14914.44918.74921.50.09
γ-Schisandrin2624.72626.92627.42630.12633.60.13
Schisandrin C2708.62710.32711.22717.82713.20.13

Interday precision was determined by repeated analysis of similar samples with intraday variabilities (i.e., continuously for three days, once every day). The RSDs of the low-concentration solutions were 0.50%, 0.70%, 0.68%, 0.34%, and 0.67%. The RSDs of the medium-concentration solutions were 0.58%, 0.69%, 0.41%, 0.50%, and 0.63%. Finally, the RSDs of the high-concentration solutions were 0.21%, 0.31%, 0.26%, 0.30%, and 0.27%. Data show that the current method was stable for 24 h and 72 h. The results are presented in Tables 68.


RSD (%)

Schizandrol A239.7241.52420.5
Schizandrol B59.059.859.60.7
Schisandrin A88.687.989.10.7
γ-Schisandrin44.444.744.50.3
Schisandrin C44.644.944.30.7


RSD (%)

Schizandrol A3697.43732.53736.20.58
Schizandrol B911.5920.6923.70.69
Schisandrin A1270.11280.21277.50.41
γ-Schisandrin672.2677.5678.50.50
Schisandrin C693.1699.9701.40.63


RSD (%)

Schizandrol A14726.314768.414787.90.21
Schizandrol B3549.53560.23571.40.31
Schisandrin A4911.34922.44936.80.26
γ-Schisandrin2624.72634.72640.10.30
Schisandrin C2708.62714.52723.20.27

3.6. Stability

To evaluate the stability of the method, the mixed working standard solutions of different concentrations were analyzed at 0, 3, 6, 9, 15, 21, and 24 h at room temperature through the developed method. The peak area was recorded, and RSD was calculated. The RSDs were 0.30%, 0.31%, 0.30%, 0.37%, and 0.48% (), which indicated that the established method was stable in a day. The results are shown in Table 9.


RSD (%)

Schizandrol A3704.63712.73704.13720.33708.23732.53742.60.30
Schizandrol B913.2915.4914918.2914.9920.69230.31
Schisandrin A1272.21272.51270.81276.21270.11280.21278.90.30
γ-Schisandrin672.6673.6676.3679677.4677.5679.20.37
Schisandrin C694.2695698.9703.1700.2699.9702.10.48

3.7. Repeatability

Six portions were accurately weighed from the same S. chinensis sample; the Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C contents were detected through the developed method; the RSDs of the samples were 0.09%, 0.76%, 1.19%, 0.34%, and 0.11%, respectively. Analyte contents were 4.46 mg/g, 2.80 mg/g, 0.70 mg/g, 2.53 mg/g, and 0.26 mg/g, respectively. The results are presented in Table 10.


RSD (%)

Schizandrol A5058.05068.65071.25068.950635066.40.09
Schizandrol B2388.62352.72353.32359.32392.82378.40.76
Schisandrin A753.4772773.1773.7777.5778.51.19
γ-Schisandrin2061.12080.22077.92078.92077.92076.60.34
Schisandrin C223.8223.8223.9223.7223.2223.70.11

3.8. Recoveries

In the recovery test, nine portions from the same sample were accurately weighed. In these portions, the amounts of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were known. After homogenously dividing these portions into three groups, 50%, 100%, and 150% of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were added separately. The resultant samples were extracted and analyzed using the developed method. The experiments were repeated three times for each level. The peak area was recorded, and then the recovery percent was calculated, which is the ratio of measured and added amounts. As shown in Tables 1113, the average recovery rate was 98.1% and the average RSD is 1.92%, which indicated that the developed method is reliable and stable.


123Quantity foundQuantity addedRecoveryRSD (%)

Schizandrol (μg/mL)56.857.257.357.10 57.5099.30 0.46
Schizandrol B (μg/mL)34.634.333.934.27 34.9098.19 1.02
Schisandrin A (μg/mL)9.59.69.19.40 9.8095.92 2.81
γ-Schisandrin (μg/mL)29.830.330.930.33 31.5096.30 1.82
Schisandrin C (μg/mL)3.23.33.33.27 3.4096.08 1.77


123Quantity foundQuantity addedRecoveryRSD (%)

Schizandrol (μg/mL)113.8113.6115.2114.20115.099.300.76
Schizandrol B (μg/mL)70.168.767.368.7069.898.422.04
Schisandrin A (μg/mL)19.118.720.319.3719.698.814.30
γ-Schisandrin (μg/mL)62.560.961.761.7063.097.941.30
Schisandrin C (μg/mL)6.56.96.36.576.896.574.65


123Quantity foundQuantity addedRecoveryRSD (%)

Schizandrol (μg/mL)173.6172.9174.2173.57 172.50100.62 0.37
Schizandrol B (μg/mL)102.8103.4104.1103.43 104.7098.79 0.63
Schisandrin A (μg/mL)28.627.929.328.60 29.4097.28 2.45
γ-Schisandrin (μg/mL)92.993.894.693.77 94.5099.22 0.91
Schisandrin C (μg/mL)10.410.19.710.07 10.2098.69 3.49

3.9. Application

By using the developed method, the analyte contents of the herbs from Heilongjiang, Liaoning, Hebei, Shanxi, Henan, and Hubei province in China were measured. Marked differences were observed in the analyte content of these samples. The S. chinensis from Hebei has the highest amount of Schizandrol A, Schizandrol B, and γ-Schisandrin. By comparison, the S. chinensis from Shanxi has the highest amount of Schisandrin A and Schisandrin C. The analyte contents of the herbs from Liaoning and Hebei were similar, in which Schizandrol A, Schizandrol B, and γ-Schisandrin were relatively high. The analyte contents were similar among the herbs from Shanxi, Hubei, and Henan, in which Schizandrol A content was high, whereas the amounts of the other lignans were low. The results are shown in Table 14.


HeilongjiangLiaoningHebeiShanxiHenanHubei

Water content (%)8.2110.748.028.409.806.98
Schizandrol (mg/g)2.115.105.500.080.010.03
Schizandrol B (mg/g)1.573.283.400.370.160.06
Schisandrin A (mg/g)3.020.801.254.854.064.07
γ-Schisandrin (mg/g)1.062.492.620.190.06
Schisandrin C (mg/g)0.470.550.480.750.640.60
Total content (mg/g)8.2412.2113.246.244.874.84

4. Conclusion

Given that Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C comprise the majority of the lignans, establishing a convenient and reliable analytical method to detect these lignans is important for the researchers. In this study, a simple method was developed for simultaneous detection of the lignans. Halstead et al. established a method to detect Schizandrol A, Schizandrol B, Schisandrin A, and γ-Schisandrin, in which each analyte can be detected within 28 min to 58 min [14].

Compared with other simple methods that do not need expensive equipment, the method developed in the present study has shorter detection time and can detect more analytes. Lee and Kim established a method to detect nine kinds of lignan, in which the detection time for Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C is 39 min. Compared with previous method, the detection time of the current method is shorter [15]. Tan et al. established a rapid detection method to determine the Schisandrin and Schisantherin A. It just costed 10 mins. Although the analytes were fewer than the essay, the detection time was rather short [16]. Moreover, the developed method exhibited high linearity, repeatability, intraday and interday assay precision, accuracy, and reliability. This method provides a simple, rapid, and sensitive technique for determination of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C by using HPLC-PDA at a single wavelength (i.e., 254 nm).

Competing Interests

The authors declare that they have no competing interests.

References

  1. O. Wang, Q. Cheng, J. Liu et al., “Hepatoprotective effect of Schisandra chinensis (Turcz.) Baill. lignans and its formula with Rubus idaeus on chronic alcohol-induced liver injury in mice,” Food & Function, vol. 5, no. 11, pp. 3018–3025, 2014. View at: Publisher Site | Google Scholar
  2. V. V. Giridharan, R. A. Thandavarayan, S. Arumugam et al., “Schisandrin B ameliorates ICV-infused amyloid β induced oxidative stress and neuronal dysfunction through inhibiting RAGE/NF-κB/MAPK and Up-regulating HSP/beclin expression,” PLoS ONE, vol. 10, no. 11, Article ID e0142483, 2015. View at: Publisher Site | Google Scholar
  3. D. Hu, Z. Yang, X. Yao et al., “Dibenzocyclooctadiene lignans from Schisandra chinensis and their inhibitory activity on NO production in lipopolysaccharide-activated microglia cells,” Phytochemistry, vol. 104, no. 8, pp. 72–78, 2014. View at: Publisher Site | Google Scholar
  4. Y. S. Kang, M. H. Han, S. H. Hong et al., “Anti-inflammatory effects of Schisandra chinensis (Turcz.) Baill Fruit through the inactivation of nuclear factor-kappaB and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated murine macrophages,” Journal of Cancer Prevention, vol. 19, no. 4, pp. 279–287, 2014. View at: Publisher Site | Google Scholar
  5. L. Opletal, M. Křenková, and P. Havlíčková, “Phytotherapeutic aspects of diseases of the circulatory system. 7. Schisandra chinensis (Turcz.) Baill.: its composition and biological activity,” Česká a Slovenská Farmacie, vol. 50, no. 4, pp. 173–180, 2001. View at: Google Scholar
  6. X. Hui, W. Xin, and G. Xin, “Simultaneous determination of five major lignans from schisandrae sphenantherae fructus and schisandrae chinensis fructus by microemulsion liquid chromatography,” Chinese Journal of Information on TCM, vol. 22, no. 5, pp. 94–98, 2015. View at: Google Scholar
  7. Z. J. Bo, L. B. Yue, S. Shibo, D. Yan, K. Zinong, and X. Wei, “Development of an automatic vacuum liquid chromatographic device and its application in the separation and its application in the separation of the components from the Schisandra chinensis,” Chinese Journal of Information on TCM, vol. 33, no. 8, pp. 864–868, 2015. View at: Google Scholar
  8. H. Liu, H. Lai, X. Jia et al., “Comprehensive chemical analysis of Schisandra chinensis by HPLC-DAD-MS combined with chemometrics,” Phytomedicine, vol. 20, no. 12, pp. 1135–1143, 2013. View at: Publisher Site | Google Scholar
  9. H. J. Kim, M. S. Oh, J. Hong, and Y. P. Jang, “Quantitative analysis of major dibenzocyclooctane lignans in schisandrae fructus by online TLC-DART-MS,” Phytochemical Analysis, vol. 22, no. 3, pp. 258–262, 2011. View at: Publisher Site | Google Scholar
  10. Q. Zhang, W. Zhu, H. Guan et al., “Development of a matrix solid-phase dispersion extraction combined with high-performance liquid chromatography for determination of five lignans from the Schisandra chinensis,” Journal of Chromatography B, vol. 1011, pp. 151–157, 2016. View at: Publisher Site | Google Scholar
  11. H. Sterbova, “Determination of lignans in Schisandra chinensis using micellar electrokinetic capillary chromatography,” Electrophoresis, vol. 23, no. 2, pp. 253–258, 2002. View at: Publisher Site | Google Scholar
  12. B. Wei, Q. Li, D. Su et al., “Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats,” Journal of Pharmaceutical and Biomedical Analysis, vol. 77, pp. 120–127, 2013. View at: Publisher Site | Google Scholar
  13. B.-L. Wang, J.-P. Hu, W. Tan, L. Sheng, H. Chen, and Y. Li, “Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis(Wuweizi) in rat plasma using liquid chromatography/mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 865, no. 1-2, pp. 114–120, 2008. View at: Publisher Site | Google Scholar
  14. C. W. Halstead, S. Lee, C. S. Khoo, J. R. Hennell, and A. Bensoussan, “Validation of a method for the simultaneous determination of four schisandra lignans in the raw herb and commercial dried aqueous extracts of Schisandra chinensis (Wu Wei Zi) by RP-LC with DAD,” Journal of Pharmaceutical and Biomedical Analysis, vol. 45, no. 1, pp. 30–37, 2007. View at: Publisher Site | Google Scholar
  15. H. J. Lee and C. Y. Kim, “Simultaneous determination of nine lignans using pressurized liquid extraction and HPLC-DAD in the fruits of Schisandra chinensis,” Food Chemistry, vol. 120, no. 4, pp. 1224–1228, 2010. View at: Publisher Site | Google Scholar
  16. X.-H. Tan, J.-M. Tian, Z.-B. Wang, N. Ma, X.-Y. Yang, and D.-S. Zhang, “Quantitative analysis of Schisandrin and Schisantherin A in Schisandra chinensis (Turcz.) Baill,” Food Research and Development, vol. 35, no. 20, pp. 91–93, 2014. View at: Google Scholar

Copyright © 2016 Yu Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

724 Views | 410 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder
 Sign up for content alertsSign up

You are browsing a BETA version of Hindawi.com. Click here to switch back to the original design.